| Drug Name |
Bupivacaine |
| Drug ID |
BADD_D00308 |
| Description |
Bupivacaine is a widely used local anesthetic agent. |
| Indications and Usage |
Bupivacaine is indicated for the production of local or regional anesthesia or analgesia for surgery, for oral surgery procedures, for diagnostic and therapeutic procedures, and for obstetrical procedures.
Bupivacaine is indicated to induce post-surgical analgesia in adults for up to 72 hours following arthroscopic subacromial decompression by administration into the subacromial space under direct arthroscopic visualization.[L31423]
Bupivacaine, together with the NSAID [meloxicam], is indicated for the production of postsurgical analgesia in adult patients for up to 72 hours following bunionectomy, open inguinal herniorrhaphy or total knee arthroplasty.[L34100] |
| Marketing Status |
approved; investigational |
| ATC Code |
N01BB01 |
| DrugBank ID |
DB00297
|
| KEGG ID |
D07552
|
| MeSH ID |
D002045
|
| PubChem ID |
2474
|
| TTD Drug ID |
D0A0FL
|
| NDC Product Code |
52945-069; 59014-0053; 65250-133; 51715-660; 57884-0038; 65250-260; 49396-6601; 65250-266; 17381-024; 72640-017; 81371-5040 |
| UNII |
Y8335394RO
|
| Synonyms |
Bupivacaine | 1-Butyl-N-(2,6-dimethylphenyl)-2-piperidinecarboxamide | Marcain | Bupivacain Janapharm | Bupivacain-RPR | Bupivacain RPR | Bupivacaina Braun | Carbostesin | Bupivacaine Carbonate | Bupivacaine Hydrochloride | Bupivacaine Monohydrochloride, Monohydrate | Buvacaina | Dolanaest | Sensorcaine | Svedocain Sin Vasoconstr | Marcaine | Bupivacaine Anhydrous |
